Vangenes

Vangenes is a private biotechnology and genetic testing company founded in 2013 in China that focuses on non-invasive reproductive health and cancer early screening services. The company uses next-generation sequencing, bioinformatics, and cell-free nucleic acid analysis to offer non-invasive prenatal paternity testing, prenatal aneuploidy screening, and multi-cancer early detection. Vangenes also markets sample collection and preservation consumables, including cfDNA/cfRNA preservation tubes, saliva collection kits, and virus sampling products. The group describes itself as headquartered in Xiamen, China, with operations or branches in Hong Kong, the United States, and Brazil. Its business appears to be primarily diagnostic services and related consumables rather than therapeutic drug development.